Get the Stockscreener App
2.06
11.59%
-0.27
After Hours:
2.10
0.04
+1.94%
Autonomix Medical Inc stock is traded at $2.06, with a volume of 39,913.
It is down -11.59% in the last 24 hours and down -24.26% over the past month.
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
See More
Previous Close:
$2.33
Open:
$2.33
24h Volume:
39,913
Relative Volume:
0.12
Market Cap:
$5.07M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-15.29%
1M Performance:
-24.26%
6M Performance:
-88.00%
1Y Performance:
-96.31%
1-Day Range:
$2.06
$2.33
1-Week Range:
$2.06
$2.68
52-Week Range:
$2.06
$82.00
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
2.06 | 5.07M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Autonomix Medical Inc Stock (AMIX) Latest News
Autonomix stock plunges to 52-week low of $2.23 amid market challenges By Investing.com - Investing.com South Africa
Autonomix Medical (NASDAQ:AMIX) versus Adagio Medical (NASDAQ:ADGM) Head-To-Head Review - Defense World
Autonomix Medical, Inc. Announces Abstract Highlighting Technology And Early Proof-Of-Concept Study Results Accepted At The Society Of Interventional Radiology (SIR) Annual Scientific Meeting - MENAFN.COM
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - GlobeNewswire
Can This New Technology Transform Pancreatic Cancer Pain Management? Major Conference Takes Notice - StockTitan
Autonomix stock hits 52-week low at $2.54 amid steep annual decline - Investing.com
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA '25 Emerging Medtech Summit - The Manila Times
Can Autonomix Medical's Nervous System Tech Disrupt the Medtech Landscape? CEO Presents Next March - StockTitan
Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting - GlobeNewswire
Can This New Catheter Technology Transform Cancer Pain Treatment? First Clinical Results Revealed - StockTitan
Autonomix Medical to Showcase Catheter-Based Technology and Clinical Trial Findings at 2025 CRT Annual Meeting - Nasdaq
Autonomix Medical, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - GlobeNewswire
Head-To-Head Contrast: KORU Medical Systems (NASDAQ:KRMD) & Autonomix Medical (NASDAQ:AMIX) - Defense World
AMIXAutonomix Medical Inc Latest Stock News & Market Updates - StockTitan
Autonomix Medical, Inc. Participates in the Virtual Investor 'Top 5 for '25” On-Demand Conference - The Manila Times
Can These 5 Growth Drivers Make Autonomix Medical the Next Big MedTech Success Story? - StockTitan
Autonomix Medical Announces Third Quarter Fiscal Year 2025 Financial Results and Operational Highlights - Defense World
Autonomix Medical reports net loss of USD 2.7M in Q3 2025 - Medical Buyer
Head-To-Head Survey: Autonomix Medical (NASDAQ:AMIX) and Profound Medical (NASDAQ:PROF) - Defense World
AUTONOMIX MEDICAL Earnings Results: $AMIX Reports Quarterly Earnings - Nasdaq
Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update - The Manila Times
Autonomix Secures $10M War Chest, Accelerates Revolutionary Cancer Pain Treatment Development - StockTitan
U.S. Patent Awarded to Autonomix for Cancerous Tumor Treatment - MPO-mag
Autonomix Medical Hires Regulatory Affairs and Quality VP - MPO-mag
Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Grows By 159.2% - Defense World
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment -January 27, 2025 at 11:05 am EST - Marketscreener.com
Financial Survey: Autonomix Medical (NASDAQ:AMIX) & Becton, Dickinson and Company (NYSE:BDX) - Defense World
Autonomix Medical, Inc. Chief Executive Officer Participated in Virtual Investor EventAutonomix Medical, Inc. (NASDAQ: AMIX) recently disclosed in an 8-K filing that its Chief Executive Officer, Brad Hauser, took part in the “Virtual Investor Closing - Defense World
Final Design Set for Autonomix Medical’s RF Ablation Catheter - MPO-mag
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - The Manila Times
Autonomix Medical CEO Shares Key Insights from JPM Healthcare Conference - StockTitan
Autonomix Medical finalizes ASIC microchip design - MSN
Autonomix Medical finalizes ASIC microchip design By Investing.com - Investing.com Canada
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, - EIN News
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip - GlobeNewswire
Autonomix Medical Locks ASIC Microchip Design, Advances Toward Pancreatic Cancer Pain Treatment - StockTitan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - The Manila Times
Autonomix Medical CEO to Present Company Vision at Virtual Investor Closing Bell Series - StockTitan
Autonomix Medical, Inc. Announces Abstract Highlighting - GlobeNewswire
Autonomix Medical to Present First Clinical Data on Novel Pancreatic Cancer Pain Treatment at SIO 2025 - StockTitan
Autonomix Medical Shares Rise on New Patent for Cancer Treatment - MarketWatch
What's Going On With Autonomix Medical Stock Monday? - Benzinga
Autonomix granted U.S. patent for catheter-based technology - TipRanks
Autonomix Medical, Inc. Announces U.S. Patent Granted - GlobeNewswire
Autonomix Medical Patents Breakthrough Cancer Pain Treatment with 3000x Greater Sensitivity - StockTitan
Autonomix Medical CEO Unveils Strategic Vision in Latest Corporate Update - StockTitan
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality - The Manila Times
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial - GlobeNewswire
Autonomix Medical Inc Stock (AMIX) Financials Data
There is no financial data for Autonomix Medical Inc (AMIX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.08%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):